Efficacy of moxifloxacin-based sequential and hybrid therapy for first-lineHelicobacter pylorieradication | Zendy

Jae Jin Hwang | Zendy; Dong Ho Lee | Zendy; Hyuk Yoon | Zendy; Cheol Min Shin | Zendy; Young Soo Park | Zendy; Nayoung Kim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy of moxifloxacin-based sequential and hybrid therapy for first-lineHelicobacter pylorieradication

Author(s) -

Jae Jin Hwang,

Dong Ho Lee,

Hyuk Yoon,

Cheol Min Shin,

Young Soo Park,

Nayoung Kim

Publication year - 2015

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v21.i35.10234

Subject(s) - rabeprazole , helicobacter pylori , moxifloxacin , medicine , metronidazole , amoxicillin , gastroenterology , urea breath test , clarithromycin , adverse effect , breath test , intention to treat analysis , antibiotics , helicobacter pylori infection , biology , microbiology and biotechnology

To evaluate the efficacy of moxifloxacin-based sequential therapy (MBST) versus hybrid therapy as a first-line treatment for Helicobacter pylori (H. pylori) infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research